Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Misop Han"'
Autor:
Christopher M Heaphy, Corinne E Joshu, John R Barber, Christine Davis, Jiayun Lu, Reza Zarinshenas, Edward Giovannucci, Lorelei A Mucci, Meir J Stampfer, Misop Han, Angelo M De Marzo, Tamara L Lotan, Elizabeth A Platz, Alan K Meeker
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 8, Iss 5, Pp 481-491 (2022)
Abstract Current biomarkers are inadequate prognostic predictors in localized prostate cancer making treatment decision‐making challenging. Previously, we observed that the combination of more variable telomere length among prostate cancer cells an
Externí odkaz:
https://doaj.org/article/d83e9cf0b5244fd6a2439370f8fc6cb4
Autor:
Jonathan I. Epstein, Elizabeth B. Humphreys, Bruce J. Trock, Jeffrey J. Tosoian, Zhaoyong Feng, Alan W. Partin, Meera Chappidi, Christian P. Pavlovich, Misop Han
Publikováno v:
BJU International. 119:676-683
Objective To update the Partin Tables for prediction of pathological stage in the contemporary setting and examine trends in patients treated with radical prostatectomy (RP) over the past three decades. Patients and Methods From January 2010 to Octob
Autor:
Christopher J. Kane, Zachary Klaassen, Lauren E. Howard, Alan W. Partin, Matthew R. Cooperberg, Stephen J. Freedland, Abhay A. Singh, Martha K. Terris, Christopher L. Amling, William J. Aronson, Bruce J. Trock, Misop Han, Zhaoyong Feng
Publikováno v:
Cancer. 121:1414-1421
Author(s): Klaassen, Zachary; Singh, Abhay A; Howard, Lauren E; Feng, Zhaoyong; Trock, Bruce; Terris, Martha K; Aronson, William J; Cooperberg, Matthew R; Amling, Christopher L; Kane, Christopher J; Partin, Alan; Han, Misop; Freedland, Stephen J | Ab
Autor:
Elizabeth B. Humphreys, Misop Han, Debasish Sundi, Trinity J. Bivalacqua, Alan W. Partin, H. Ballentine Carter, Edward M. Schaeffer, Farzana A. Faisal, Ashley E. Ross, Jonathan I. Epstein, Phillip M. Pierorazio, Mark W. Ball
Publikováno v:
BJU International. 114:E120-E129
Objective To investigate the post-prostatectomy and long-term outcomes of men presenting with an elevated pretreatment prostate-specific antigen (PSA) level (>10 ng/mL), but otherwise low-risk features (biopsy Gleason score ≤6 and clinical stage
Autor:
Charles G. Drake, Misop Han, Seung Bae Lee, Paul M. Ness, Bruce J. Trock, Elizabeth B. Humphreys, Zhaoyong Feng, Alan W. Partin, Byong Chang Jeong, Steven M. Frank, Heather J. Chalfin
Publikováno v:
Transfusion. 54:2168-2174
Blood transfusion (BT) is among the most common hospital procedures, with an estimated 15 million units transfused annually in the United States alone.1 Ideally, indications for BT should be optimized to prevent overuse of a costly resource with pote
Autor:
Phuoc T. Tran, Trinity J. Bivalacqua, Debasish Sundi, Vinson Wang, Alan W. Partin, Ashley E. Ross, Phillip M. Pierorazio, Misop Han
Publikováno v:
The Prostate. 74:628-636
BACKGROUND Men destined to have early biochemical recurrence (BCR) following radical prostatectomy (RP) may be optimal candidates for multimodal treatment. Here we identified pre-operative predictors of early BCR within a surgical cohort who recurred
Autor:
Trinity J. Bivalacqua, Misop Han, Edward M. Schaeffer, Jonathan I. Epstein, Patrick C. Walsh, Phillip M. Pierorazio, Alan W. Partin, Ashley E. Ross, Bruce J. Trock, Zhaoyong Feng, Michael A. Gorin
Publikováno v:
The Prostate. 73:1673-1680
BACKGROUND We report the 30-year institutional experience of radical prostatectomy (RP) for men with clinically localized prostate cancer (PC) found to have lymph node (LN) metastases at surgery. METHODS The Johns Hopkins RP Database (1982–2011) wa
Autor:
Mohamad E. Allaf, Ashley E. Ross, Patrick C. Walsh, Misop Han, Phillip M. Pierorazio, Christian P. Pavlovich, Alan W. Partin, Elias S. Hyams, Jeffrey K. Mullins, Edward M. Schaeffer, Trinity J. Bivalacqua
Publikováno v:
BJU International. 112:45-53
What's known on the subject? and What does the study add? Standard clinical care pathways to discharge have been established for a number of operations including radical prostatectomy (RP). The pathway after RP has changed dramatically over the past
Autor:
Edward M. Schaeffer, Mohamad E. Allaf, Alan W. Partin, Misop Han, Christian P. Pavlovich, John B. Eifler, Kipp Voth, Phillip M. Pierorazio, Jeffrey K. Mullins, Trinity J. Bivalacqua, Elias S. Hyams
Publikováno v:
BJU International. 112:751-757
What's known on the subject? and What does the study add? The ideal treatment for men with high-risk prostate cancer is controversial, although most physicians agree that a multimodal approach, including radiation and hormone therapy with or without
Autor:
Bruce J. Trock, Jonathan I. Epstein, Brian M. Lin, John B. Eifler, Michael T. Partin, Elizabeth B. Humphreys, Patrick C. Walsh, Zhaoyang Feng, Alan W. Partin, Misop Han
Publikováno v:
BJU International. 111:22-29
Objective To update the 2007 Partin tables in a contemporary patient population. Patients and Methods The study population consisted of 5,629 consecutive men who underwent RP and staging lymphadenectomy at the Johns Hopkins Hospital between January 1